AbbVie (NYSE:ABBV) is scheduled to announce Q4 earnings results on Friday, January 31st, before market open. Analysts expect ...

Earnings season marches on, and we're here to spotlight the companies set to unveil their financial results in the next trading day. As Friday approaches, investors are eagerly anticipating reports ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $212.73, a high ...

AbbVie (ABBV) is one of the stocks most watched ... And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward.

Citi lowered the firm’s price target on AbbVie (ABBV) to $205 from $215 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the ...

Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

AbbVie (NYSE:ABBV) will report Q4 2024 results ... being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those ...

Well before the market open, news broke of those two AbbVie price target increases ... Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever 3 High ...

Investors who were hoping for huge dividend increases may want to adjust their expectations. Today, AbbVie's dividend payout ratio is 61% of 2024 earnings. That leaves plenty of room for future ...